Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US7142901039
Ticker PRGO
Company PERRIGO
Currency $
Price
Aware Investor Index (AII) 0.0005
Recommendation STRONG SELL
P/E 49.40
ROE 2.23 %
Capitalization 11,039,316,000 $
Dividend Yield 0.61 %
P/S 2.40
AII Position 737
P/E Position 597
ROE Position 764
Capitalization Position 482
Dividend Yield Position 585
Sales 4,603,900,000 $
10-Year Average Earnings 223,476,200 $
Shares Outstanding 146,100,000
Equity 10,036,100,000 $
Dividend per Share 0.46 $
Industry Pharmaceutical
Country United States
PERRIGO Investor Relations Web Site http://perrigo.investorroom.com/







Sales:

YEAR MONTH AMOUNT
2015 12 4,603,900,000.00 $
2014 6 4,060,800,000.00 $
2013 6 3,539,800,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 133,600,000.00 $
2014 6 205,300,000.00 $
2013 6 441,900,000.00 $
2012 6 401,613,000.00 $
2011 6 339,197,000.00 $
2010 6 223,799,000.00 $
2009 6 145,533,000.00 $
2008 6 134,250,000.00 $
2007 6 135,773,000.00 $
2006 6 73,797,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 10,036,100,000.00 $
2015 6 10,662,800,000.00 $
2014 6 8,693,700,000.00 $
2013 6 2,332,600,000.00 $
2012 6 1,852,645,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 146,100,000
2015 6 139,800,000
2014 6 115,600,000
2013 6 94,500,000
2012 6 94,052,000

 












Bloomberg News for PERRIGO:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
748 26,873 PESI PERMA-FIX ENVIR 74,487 79,459 93,032 PRGO PERRIGO CO 4,853,676 4,055,032 790,427 PERY PERRY ELLIS INTL...
May 3, 2011
Alvarion, Perrigo, Ratio Oil, Teva: Israeli Equity Preview
million from $4.9 million a year earlier. Alvarion climbed 1 percent to 5.765 shekels. Perrigo Co. (PRGO IT): The maker of over-the-counter drugs received a final approval from the U.S. Food and Drug...
Apr 14, 2011
Israeli Stocks: D-Pharm, Perrigo, Ratio Oil, Teva Pharmaceutical
ischemic stroke was put on “fast-track” status by the U.S. Food and Drug Administration. Perrigo Co. (PRGO IT) gained for a fifth day, increasing 1.4 percent to 299.80 shekels as partner Teva Pharmaceutical...
Oct 30, 2008
Generics Are Gaining on Name Brands
of private labels may keep customers coming back. Products from manufacturers such as Perrigo (PRGO), TreeHouse Foods (THS), Home Diagnostics (HDIX), and Ralcorp Holdings (RAH) have evolved to name-brand...
Sep 2, 2005
Oppenheimer Ups Perrigo To Buy
Oppenheimer upped its opinion on Perrigo (PRGO ) to buy from neutral on Friday, explaining that the over-the-counter drug retailer's stock price already reflects uncertainties. ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
% CHG Q/E ============================================================================ 5/7 PRGO Perrigo Company 1.42 1.21 17.4 1.44 -1.4 Mar 4/24 TMO Thermo Fisher Scientifi...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
========== 5/1 AGN Allergan Inc/United Sta 0.98 0.83 18.1 0.96 2.1 Mar 5/7 PRGO Perrigo Company 1.42 1.21 17.4 1.44 -1.4 Mar 4/24 TMO Thermo Fisher Scientifi...
Nov 6, 2012
Indicated Dividend Yield Rankings of S&P 500 Companies
05 2.8 10/30/2012 TXT Textron Inc 0.31 0.02 9.1 10/24/2012 PRGO Perrigo Co 0.27 0.08 7.4 8/15/2012 MA Mastercard Inc ...
Mar 1, 2012
Indicated Dividend Yield Rankings of S&P 500 Company
09 8.3 2/16/2012 COF Capital One Financial Cor 0.40 0.05 2.8 1/31/2012 PRGO Perrigo Co 0.32 0.08 7.4 2/2/2012 TXT Textron Inc ...
Nov 14, 2011
Orbimed Advisors Holdings in 3rd Quarter: 13F Alert
Squibb Co BMY US -36,803,104 3,364,800 -1,552,000 Perrigo Co PRGO US -28,551,423 64,400 -331,700 SOURCE: SEC 13F-HR FILER: Orbimed Advisors...


Google News for PERRIGO:

Nasdaq - 10 Aug 2017
Perrigo (PRGO) Q2 Earnings & Sales Top, 2017 View Raised
Perrigo Company plc PRGO reported second-quarter 2017 earnings of $1.22 per share, which beat the Zacks Consensus Estimate of 95 cents ...
StreetInsider.com - 1 day ago
Perrigo (PRGO) Receives FDA Final Approval for AB Rated Generic ...
Perrigo Company plc (NYSE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for its AB ...
Benzinga
Perrigo (PRGO) to Sell Active Pharmaceutical Ingredients Business ...
SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced that it has signed ...
Highlight Press
September 22nd Options Now Available For Perrigo (PRGO)
Investors in Perrigo Company plc (Symbol: PRGO) saw new options become available today, for the September 22nd expiration. At Stock ...
StreetInsider.com - 10 Aug 2017
Perrigo Plc (PRGO) Q2 2017 Results - Earnings Call Transcript
Good morning. My name is Hope and I will be your conference operator today. At this time, I would like to welcome everyone to the Perrigo ...
Globes
Why Perrigo is Soaring
And Perrigo (PRGO) definitely did something right. ... Perrigo also said it expects to report earnings between $4.46 and $4.70 a share in 2017, ...
TheStreet.com
Perrigo (PRGO) Tops Q2 EPS by 29c, Raises FY EPS Guidance
Perrigo (NYSE: PRGO) reported Q2 EPS of $1.22, $0.29 better than the analyst estimate of $0.93. Revenue for the quarter came in at $1.24 ...
Nasdaq - 3 Aug 2017
Perrigo (PRGO) Receives Tentative FDA Approval For Generic ...
Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received tentative approval from the U.S. Food and Drug Administration for ...
Seeking Alpha - 10 Aug 2017
Perrigo Company (PRGO) Q2 Earnings: What's in the Cards?
Perrigo Company plc PRGO is expected to report second-quarter 2017 results before the opening bell on Aug 10. Overall, the company has an ...
Barron's - 10 Aug 2017
Perrigo (PRGO) Earns News Sentiment Rating of 0.12
Perrigo logo Headlines about Perrigo (NYSE:PRGO) have trended somewhat positive this week, according to Accern Sentiment. The research ...


Back